Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.850
-0.040 (-2.12%)
At close: Apr 28, 2026, 4:00 PM EDT
1.850
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:03 AM EDT
Annovis Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -28.85 | -24.59 | -56.2 | -25.33 | -14.49 | |
| Stock-Based Compensation | 1.8 | 3.84 | 4.63 | 9.15 | 4.7 | |
| Other Operating Activities | -0.14 | -1.82 | 11.84 | - | - | |
| Change in Accounts Payable | 0.28 | 1.01 | -2.67 | 3.27 | 0.35 | |
| Change in Other Net Operating Assets | 1.29 | -0.33 | 2.44 | -4.41 | 0.31 | |
| Operating Cash Flow | -25.62 | -21.89 | -39.97 | -17.31 | -9.13 | |
| Issuance of Common Stock | 34.6 | 26.69 | 17.34 | 0 | 46.74 | |
| Financing Cash Flow | 34.6 | 26.69 | 17.34 | 0 | 46.74 | |
| Net Cash Flow | 8.98 | 4.8 | -22.62 | -17.31 | 37.61 | |
| Levered Free Cash Flow | -15.18 | -12.17 | -23.75 | -7.93 | -3.73 | |
| Unlevered Free Cash Flow | -15.18 | -12.17 | -23.75 | -7.93 | -3.73 | |
| Change in Working Capital | 1.58 | 0.68 | -0.23 | -1.14 | 0.66 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.